EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RayChaudhury, A.
Right arrow Articles by Nakada, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RayChaudhury, A.
Right arrow Articles by Nakada, M. T.
Experimental Biology and Medicine 226:686-691 (2001)
© 2001 Society for Experimental Biology and Medicine

ORIGINAL ARTICLE

Regulation of PECAM-1 in Endothelial Cells during Cell Growth and Migration

Amlan RayChaudhury*,1, Marne Elkins*, Dianna Kozien* and Marian T. Nakada{dagger}

* Department of Pharmacology, Rush Medical College, Chicago, Illinois 60613;
{dagger} Centocor, Malvern, Pennsylvania 19355

Endothelial cells (EC) that form the inner lining of blood vessels remain quiescent in the normal adult vasculature except during angiogenesis and reendothelialization, which result in EC proliferation and migration. EC placed in culture at subconfluent density also undergo cell multiplication and movement. This report demonstrates that whereas in confluent EC in a compact monolayer, the EC-EC adhesion molecule platelet-endothelial cell adhesion molecule-1 (PECAM-1) is strongly expressed at cell borders, little or no PECAM-1 immunostaining is detected in sparse or migrating cultured EC. Consistent with this observation, steady-state PECAM-1 mRNA expression was much lower in subconfluent EC than in confluent EC. The absence of PECAM-1 expression in sparse EC appeared not to be linked to ability to proliferate, since PECAM-1 expression remained low even in the presence of nitric oxide (NO) or mitomycin C, agents that inhibit EC growth. However, another growth-inhibitory agent, TGF-ß1, did not alter PECAM-1 staining. Based on these observations, it is hypothesized that cell-associated mechanical forces underlying cell tensegrity regulate PECAM-1 expression.

Key Words: angiogenesis • endothelial cell • PECAM-1 (CD31) • re-endothelialization • tensegrity • TGF-ß1




This article has been cited by other articles:


Home page
 Therapeutic Advances in GastroenterologyHome page
M. Kukla, K. Zwirska-Korczala, A. Gabriel, E. Janczewska-Kazek, A. Berdowska, A. Wiczkowski, B. Rybus-Kalinowska, M. Kalinowski, A. Ziolkowski, E. Wozniak-Grygiel, et al.
sPECAM-1 and sVCAM-1: role in pathogenesis and diagnosis of chronic hepatitis C and association with response to antiviral therapy
Therapeutic Advances in Gastroenterology, March 1, 2009; 2(2): 79 - 90.
[Abstract] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. S. Lim, F. Alexander-Sefre, M. Allam, N. Singh, J. C. Aleong, H. Al-Rawi, and I. J. Jacobs
Clinical Value of Immunohistochemically Detected Lymphovascular Space Invasion in Early Stage Cervical Carcinoma
Ann. Surg. Oncol., September 1, 2008; 15(9): 2581 - 2588.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Joner, G. Nakazawa, A. V. Finn, S. C. Quee, L. Coleman, E. Acampado, P. S. Wilson, K. Skorija, Q. Cheng, X. Xu, et al.
Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 333 - 342.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Experimental Biology and Medicine.